ALPROLIX

Google image searchProduct monograph

Active ingredient

recombinant human coagulation factor ix, fc fusion protein, 500 UNIT/VIAL

DIN: 02422913

Dosage form(s): KIT, POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL & 5 ML PREFILLED DILUENT SYRINGE

Schedule: Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 13-MAY-2022

ATC:

• B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
• B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
• B02BD — Blood coagulation factors (ATC, ATC/DDD)
• B02BD04 — COAGULATION FACTOR IX (ATC/DDD)

Reference brand drug: Benefix, Rixubis, Rebinyn, Immunine Vh, Alprolix

External Links for Alprolix

Search on Google

• Alprolix side effects
• Alprolix dosage
• recombinant human coagulation factor ix, fc fusion protein side effects
• recombinant human coagulation factor ix, fc fusion protein dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find alprolix photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.